Calcium antagonists: Not appropriate as first line antihypertensive agents

American Journal of Hypertension

Volumn 9, Issue 2, 1996, Pages 122-125

  Furberg, Curt D ^a   Psaty, Bruce M ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIHYDROPYRIDINE DERIVATIVE; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; ISRADIPINE; MANIDIPINE; NIFEDIPINE; THIAZIDE DIURETIC AGENT;

CONFERENCE PAPER; DRUG MECHANISM; HUMAN; HYPERTENSION; PRIORITY JOURNAL;

EID: 0029968441     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00014-3     Document Type: Conference Paper

References (13)

1. Epstein M: Calcium antagonists: still appropriate as first-line antihypertensive agents. Am J Hypertens 1996;9:110-121.
2. Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: effect of encainide and flecainide in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1988; 321:405-412.
3. Rossouw JE: Non-CHD mortality in cholesterol-lowering trials. Cardiovasc Risk Factors 1995;5:181-188.
4. Cutler JA, Psaty BM, MacMahon S, Furberg CD: Public health issues in hypertension control: what has been learned from clinical trials, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management, 2nd ed. Raven Press, New York, 1995, pp. 253-279.
5. Neaton JD, Grimm RH, Jr., Prineas RJ, et al for the Treatment of Mild Hypertension Research Group: Treatment of Mild Hypertension Study (TOMHS): final results. JAMA 1993;270:713-724.
6. Gong L, Zhang W, Zhu Y, Zhu J, et al: Shanghai Trial of Nifedipine in the Elderly (STONE) (abst). Seventh European Meeting on Hypertension, Milan, June 1995.
7. McClellan K: Unexpected results from MIDAS in atherosclerosis. Inpharma 1994;932:4.
8. Ferguson JJ, Momomura S: Highlights from the 58th Annual Scientific Meeting of the Japanese Circulation Society. Circulation 1994;90:2194-2196.
9. Omae T, Matsuoka H, Arakawa K, et al: A 12-month comparison of ACE inhibitor and Ca antagonist therapy in mild to moderate essential hypertension: the GLANT Study Group. Hypertens Res 1995;18:235-244.
10. Psaty BM, Heckbert SR, Koepsell TD, et al: The risk of myocardial infarction associated with anti-hypertensive drug therapies. JAMA 1995;274:620-625.
11. Pahor M, Guralnik JM, Corti M-C, et al: Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-1197.
12. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
13. McKenney JM, Proctor JD, Harris S, Chinchili VM: A comparison of the efficacy and toxic effects of sustained-vs immediate-release niacin in hypercholesterolemic patients. JAMA 1994;271:672-677.